36C25726Q0481_1.docx
DOCX document 16 KB Posted
- Attached to
- 6640--Brand Name or Equal Molecular Diagnostic Systems Federal contract opportunity
- Solicitation number
- 36C25726Q0481
About this file
This is a Combined Synopsis/Solicitation Notice (Request for Quote) issued by the Department of Veterans Affairs Network Contracting Office for the procurement of four (4) Molecular Diagnostics Testing Systems. The Texas Valley Coastal Bend Healthcare System requires these instruments for four Pathology & Laboratory Medicine Service locations: Harlingen Care Center, McAllen Outpatient Clinic, Corpus Christi Specialty Clinic, and Laredo Outpatient Clinic in Texas. The systems must identify pathogens by detecting genetic material (DNA or RNA) using Polymerase Chain Reaction (PCR) techniques and must meet or exceed the specifications of the Cepheid GeneXpert Express System (brand name or equal). Each fully operational system must include all software, UPS, printer, technical support, customer training, and a business hours service plan.
Quotations are due by May 5, 2026 at 1:00 PM Eastern Time, with technical questions accepted until April 28, 2026 at 1:00 PM EST via email to Kathryn Prose at kathryn.prose@va.gov. Offerors must submit a detailed price quote including unit price, extended price, total price, manufacturer numbers, and must clearly identify shipping, installation, and training costs as Not Separately Priced (NSP) items. Additional required documentation includes a product description demonstrating compliance with the Statement of Work, technical evaluation criteria comparison, an OEM authorization letter (if not the original manufacturer), estimated delivery timeframe, completion of the Small Business Representation provision (RFO 52.219-1), and a Trade Agreement Certificate (RFO 52.225-6). Evaluation will be based on technical compliance (equipment specifications, warranty, training, installation, and delivery timeline) and price reasonableness compared to the Independent Government Estimate and competing quotations. The Government reserves the right to select the quotation providing the best overall value rather than the lowest price.
View the file
Other files for this federal contract opportunity
| File | Type | Posted |
|---|---|---|
| RFQ 36C25726Q0481.docx | DOCX document | |
| RFQ 36C25726Q0481.pdf |
On GovTribe
Work with this file on GovTribe
- Download the original file
- Contacts named in this file
- Similar government files
- Ask GovTribe AI about this file
Text version
Combined Synopsis/Solicitation Notice Combined Synopsis/Solicitation Notice
| SUBJECT* |
| Brand Name or Equal Molecular Diagnostic Systems |
GENERAL INFORMATION
| CONTRACTING OFFICE’S ZIP CODE* |
| 78240 |
| SOLICITATION NUMBER* |
| 36C25726Q0481 |
| RESPONSE DATE/TIME/ZONE |
| 05-05-2026 1:00 PM EASTERN TIME, NEW YORK, USA |
| ARCHIVE |
| 90 DAYS AFTER THE RESPONSE DATE |
| RECOVERY ACT FUNDS |
| N |
SET-ASIDE
| PRODUCT SERVICE CODE* |
| 6640 |
| NAICS CODE* |
| 334516 |
| CONTRACTING OFFICE ADDRESS |
| Department Of Veterans Affairs |
Network Contracting Office 17
5441 Babcock Road Ste. 302 San Antonio TX 78240
POINT OF CONTACT*
Contracting Officer Kathryn Prose kathryn.prose@va.gov
(254) 217-2835
PLACE OF PERFORMANCE
| ADDRESS |
| Department of Veteran Affairs |
Texas Valley Coastal Bend Healthcare System
2601 Veterans Drive
Harlingen TX
| POSTAL CODE |
| 78550 |
| COUNTRY |
| USA |
ADDITIONAL INFORMATION
AGENCY’S URL
URL DESCRIPTION
AGENCY CONTACT’S EMAIL ADDRESS
EMAIL DESCRIPTION
DESCRIPTION
The Texas Valley Coastal Bend Healthcare System (TXVCBHCS) has a requirement for four (4) Molecular Diagnostics Testing Systems for molecular testing. These instruments are required for four (4) Pathology & Laboratory Medicine Service (P&LMS) locations to include Harlingen Care Center (HCC), McAllen Outpatient Clinic (MOPC), Corpus Christie Specialty Clinic (CCSC) and Laredo Outpatient Clinic (LOPC). The molecular analyzers must include all system software, UPS, printer, technical support, customer training, and a business hours service plan.
The Molecular Diagnostics Testing Systems shall identify pathogens by detecting their unique genetic material (DNA or RNA). The systems shall use Polymerase Chain Reaction (PCR) techniques. The equipment should meet or exceed the specifications below for brand name or equivalent to the Cepheid GeneXpert Express System.
Technical Questions. Technical questions shall be accepted by the Government in writing via email no later than 1:00 PM Eastern Standard Time (CST), 04/28/2026. Please list “Technical Questions – 36C25726Q0481, Molecular Diagnostic Instruments” in the subject line of the e-mail and send to Kathryn Prose, Contract Specialist, at kathryn.prose@va.gov. Please include in your questions the section of the solicitation/page number that your question is referencing. The Government reserves the right not to answer questions without meeting this timeline if doing so would result in an amendment requiring an extension of the solicitation and to extend it would not be in the best interest of the Government. No questions about this solicitation will be answered telephonically. All responses to questions, which may affect offers, will be incorporated into a written amendment to the Request for Quote.
To be considered for the award, the following documents, at a minimum, must be included:
Submit a price quote on offerors own format. The pricing must include the unit price, extended price and total price. The offerors’ pricing should include all components required that establish fully operational systems for each location. Pricing must include the manufacturer number and / or offeror’s item number.
The quote must specifically address line items that are included in the price of the instruments such as shipping, installation, and training. The proposed price for such items should be labeled as Not Separately Priced (NSP) in the quote.
The offeror must state the place of manufacturer for the items being offered by completing the Trade Agreement Certificate, RFO Provision 52.225-6 at paragraph E.5.
The offeror must complete the RFO Provision 52.219-1, Small Business Representation at E.4.
Provide a description of the proposed Molecular Diagnostic Instruments that meet the requirements of the SOW.
Provide documentation demonstrating how vendor will be able to meet all the requirements described in the Statement of Work and technical evaluation criteria described in Provision FAR 52.212-2 Evaluation – Commercial Products and Commercial Services. This can be done through a direct comparison to the Statement of Work and/or providing product literature. All criteria must be addressed.
If not the Original Equipment Manufacturer (OEM), a letter signed by the OEM stating that the vendor is authorized to provide supplies.
Provide estimated delivery timeframe after receipt of the award.
Evaluation Approach. The Government will evaluate quotations using the comparative evaluation process outlined in RFO 12.203(c)(2), where quotations will be compared to one another to determine which provides the best benefit to the Government. The Government reserves the right to consider a quotation other than the lowest price that provides additional benefit(s). Quotations may exceed the minimum requirements of the solicitation. The Government reserves the right to select a quotation that provides benefit to the Government that exceeds the minimum requirements of the solicitation but is not required to do so. Each response must meet the minimum requirements of the solicitation. The Government is not requesting or accepting alternate quotations. The evaluation will consider the following:
Technical.
1. The Molecular Diagnostic Equipment must meet or exceed all requirements listed in the instrument capability, performance, dimension, and testing requirements if the SOW.
2. Warranty must meet or exceed the requirements of the SOW.
3. Training provided must meet or exceed the requirements of the SOW.
4. Installation services as described in the SOW.
5. Vendor provides an estimated timeline for deliveries.
Price
1. Provide prices on all line items listed on the Price/Cost Schedule and any components required for fully operational systems.
2. In this factor, price will be evaluated for reasonableness, completeness, and fairness by comparing the proposed prices with the Independent Government Estimate and prices posed by other offerors.
3. In evaluating the offeror’s proposed price for this project, the techniques and procedures described under RFO 12.204(a), Price reasonableness, will be the primary means of assessing proposal reasonableness.
See attached document: RFQ 36C25726Q0481.
See attached document: RFQ 36C25726Q0481.
| *= Required Field |
| Combined Synopsis/Solicitation Notice |
Combined Synopsis/Solicitation Notice
File details come from the government source that posted it. Updated .